| Case Study |
|
Using an Online Safety Reporting System to Track Pharmacist Clinical Interventions By Barbara Giacomelli, PharmD, MBA Pharmacists Recognize the value of reporting their interventions during the subsequent action planning that occurs to correct identified issues. Click here to download the PDF
In 2000, Shore Memorial Hospital, a nonprofit, 296-bed community hospital in southern New Jersey, developed a database to track safety events. The program, known as the SMH Safety and Quality Tracking Database, was developed to provide online reporting of adverse drug events, medication events, and other hospital-related safety events. Implementation of the database has since eliminated manual reporting of events and has met the hospital’s liability insurance carrier’s requirements for reporting, investigation, and follow-up for events. The online database has also allowed for anonymous reporting, which met the hospital’s goal of a non-punitive approach to event reporting.
The database was designed by a member of our IT department, with feedback from key users. The system integrates with the hospital’s information system to auto-populate patient demographic and hospital formulary information, thereby reducing our documentation steps and standardizing the reporting process.
Reported events are reviewed by the quality assurance staff and assigned to the appropriate managers for investigation and follow-up. Serious events result in a phone call from quality assurance to the manager for immediate follow-up and eventually a “root cause analysis” meeting. Reports are generated from the database by the different reporting categories, which allow for the identification of trends. Various committees review the reports and information in the database as part of their action planning and process improvement activities.
Tracking Pharmacist Interventions
After several meetings with IT, documentation screens were developed (See Figure 1) to integrate intervention tracking with the SMH Safety and Quality Tracking Database. Each pharmacist was assigned his or her own user name and password, allowing us to track interventions by pharmacist. Training of the pharmacy staff was completed in small groups, and we reinforced that documenting interventions was the approved process to demonstrate the effectiveness of pharmacists’ clinical activities. It was also reinforced that order clarifications play a role in avoiding potential medication events. The database is available on every networked PC in the hospital, so pharmacists can easily access it during their decentralized activities. Reports were developed to track and trend interventions by category, medical staff, and reporting pharmacist.
Results
A pre-printed anti-infective order form was implemented to ensure approved guidelines for use were followed. A pharmacist rounds with infectious disease physicians twice weekly.
Diuretic administration times were changed. An alert for nurses was added for medications that can increase the risk of falls.
A decentralized pharmacist works in the ED from 1:00 to 8:30PM on weekdays and reviews orders prior to medications being pulled from the automated dispensing system. Pharmacists recognize the value of reporting their interventions during the subsequent action planning that occurs to correct identified issues. They continue to provide input for streamlining the reporting process, including the implementation of drop-down menus with common intervention options, a pre-built list of prescribers with hospital privileges, and standardized cost-avoidance tracking. Since beginning to track pharmacist interventions online, a new pharmacy information system, with its own intervention documentation tool, has been installed. After reviewing the steps involved in documenting with the new tool, our pharmacists opted to continue documenting interventions with the SMH Safety and Quality Tracking Database, because of the database’s link to our event-reporting system. This link enables integrated trending of retrospectively reported medication events and avoidance of medication events through pharmacist clinical interventions. Our pharmacists also value our database’s ease of use and our ability to customize the reporting screens in the database. As pharmacy expands its clinical monitoring of drug therapy, such as automatic dosing adjustment for erythropoietin stimulating agents, the database can be adjusted to allow documentation of these activities.
Conclusion
Barbara Giacomelli, PharmD, MBA, is the pharmacy director at Shore Memorial Hospital. She has been in pharmacy management for over 20 years.
|
| Next > |
|---|


